Tuesday, June 28, 2005

Lilly to Settle Zyprexa Claims

"Eli Lilly announced late Thursday that it will settle about three-quarters of the liability clams stemming from its Zyprexa schizophrenia drug.

"Lilly will establish a fund not to exceed $690 million for plaintiffs who agree to settle their claims. The number of claimants covered by the settlement is estimated to be 8,000, comprising about 75% of the claims." [ThsStreet.com]